• 1. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes Nitrophenyl ethers

2-Nitro-4-(trifluoromethoxy)anisole: A Versatile Compound in Modern Pharmaceutical Research

2-Nitro-4-(trifluoromethoxy)anisole, with the chemical identifier CAS No. 660848-54-4, represents a significant advancement in the field of medicinal chemistry. This compound, characterized by its unique molecular structure containing a nitro group and a trifluoromethoxy functional group, has garnered attention for its potential applications in pharmaceutical development. The combination of these functional groups contributes to its distinct chemical properties, making it a valuable candidate for further exploration in drug discovery and therapeutic innovation.

Recent studies have highlighted the importance of 2-Nitro-4-(trifluoromethoxy)anisole in the context of antimicrobial activity and anti-inflammatory properties. Researchers have demonstrated that the presence of the trifluoromethoxy group enhances the compound's ability to interact with biological targets, potentially leading to improved therapeutic outcomes. This molecular feature is particularly relevant in the development of new drugs targeting infectious diseases and chronic inflammatory conditions.

The 2-Nitro-4-(trifluoromethoxy)anisole molecule exhibits a unique electronic configuration that influences its reactivity and stability. The nitro group, known for its electron-withdrawing properties, plays a crucial role in modulating the compound's interaction with biological systems. This characteristic is essential for optimizing the pharmacokinetic profile of the compound, ensuring effective drug delivery and target-specific action.

Recent advancements in computational chemistry have enabled researchers to predict the behavior of 2-Nitro-4-(trifluoromethoxy)anisole in various biological environments. These simulations provide valuable insights into the compound's potential applications in targeted drug delivery and nanomedicine. By leveraging these computational tools, scientists can design more effective therapeutic strategies that incorporate the unique properties of this compound.

The trifluoromethoxy group in 2-Nitro-4-(trifluoromethoxy)anisole is particularly noteworthy for its hydrophobic nature, which enhances the compound's ability to penetrate biological membranes. This property is critical for the development of lipophilic drugs that can effectively reach their intended targets within the body. Additionally, the trifluoromethoxy group contributes to the compound's metabolic stability, reducing the risk of rapid degradation in vivo.

Studies have also explored the cytotoxic effects of 2-Nitro-4-(trifluoromethoxy)anisole on various cell lines, providing insights into its potential anti-cancer properties. Researchers have observed that the compound exhibits selective toxicity toward certain cancer cell types, suggesting its potential as a chemotherapeutic agent. These findings underscore the importance of further in vitro and in vivo studies to evaluate its safety and efficacy in clinical settings.

The nitro group in 2-Nitro-4-(trifluoromethoxy)anisole is known to participate in electrophilic substitution reactions, which can be harnessed for the synthesis of derivatives with enhanced therapeutic profiles. By modifying the molecular structure of this compound, scientists can tailor its properties to address specific disease mechanisms and pathological conditions. This approach is particularly relevant in the development of personalized medicine and precision therapies.

Recent advances in drug delivery systems have opened new avenues for the application of 2-Nitro-4-(trifluoromethoxy)anisole. Researchers are exploring the use of nanoparticles and liposomes to enhance the compound's bioavailability and targeted delivery. These delivery systems can significantly improve the therapeutic index of the compound, reducing potential side effects while maximizing its pharmacological activity.

The trifluoromethoxy group also plays a role in the photophysical properties of 2-Nitro-4-(trifluoromethoxy)anisole, making it a promising candidate for photodynamic therapy applications. This property allows the compound to absorb light at specific wavelengths, enabling the generation of reactive oxygen species that can target cancer cells or pathogenic microorganisms. This dual functionality highlights the versatility of the compound in multimodal therapeutic approaches.

Furthermore, the 2-Nitro-4-(trifluoromethoxy)anisole molecule has been investigated for its potential anti-viral activity against various pathogens. Studies have shown that the compound can inhibit the replication of certain viral strains, making it a potential candidate for the development of antiviral drugs. These findings are particularly significant in the context of epidemic outbreaks and global health security.

The electronic properties of 2-Nitro-4-(trifluoromethoxy)anisole are also being explored for applications in electrochemical sensors and biosensors. The compound's ability to interact with electrochemical signals makes it a valuable component in the development of point-of-care diagnostic tools. These sensors can provide rapid and accurate detection of biomarkers associated with various diseases, enabling early diagnosis and intervention.

In conclusion, the unique chemical properties of 2-Nitro-4-(trifluoromethoxy)anisole make it a promising candidate for further research and development in the field of pharmaceutical sciences. The compound's potential applications in antimicrobial therapy, anti-inflammatory treatments, anti-cancer drugs, and viral infection prevention underscore its significance in modern medicine. Continued scientific inquiry and innovative research are essential to fully realize the therapeutic potential of this compound and to address the challenges of disease management and healthcare innovation.

As the field of pharmaceutical research continues to evolve, the role of compounds like 2-Nitro-4-(trifluoromethoxy)anisole will become increasingly important. The integration of computational methods, biomolecular engineering, and advanced drug delivery systems will enable the development of more effective and targeted therapies. These advancements will not only enhance the efficacy of existing treatments but also pave the way for the discovery of new therapeutic agents that can address a wide range of health challenges.

The exploration of 2-Nitro-4-(trifluoromethoxy)anisole also highlights the importance of interdisciplinary collaboration in modern scientific research. By combining expertise from fields such as chemistry, biology, and engineering, researchers can overcome the complexities of drug development and bring innovative solutions to the forefront of medical science. This collaborative approach is essential for advancing the frontiers of knowledge and improving the quality of healthcare for patients worldwide.

In summary, the chemical properties and potential applications of 2-Nitro-4-(trifluoromethoxy)anisole represent a significant area of interest in pharmaceutical research. The compound's unique characteristics offer a wide range of opportunities for therapeutic innovation and healthcare advancement. As research in this field continues to progress, the role of compounds like 2-Nitro-4-(trifluoromethoxy)anisole will become increasingly critical in addressing the complex challenges of modern medicine and global health.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)